MedTrace Logo

The Singapore Tele-technology Aided Rehabilitation in Stroke (STARS) Study

NCT01905917 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 124

Last updated 2017-09-13

No results posted yet for this study

Summary

The primary hypothesis tested in this randomized control trial is that a tele-rehabilitation intervention involving video-conferencing with a therapist and use of wearable monitoring devices in the first three months after stroke results greater functional recovery using the Jette Late Life Functional and Disability Instrument (LLFDI) (primary outcome) among stroke at three months survivors compared to usual care.

The secondary hypotheses tested in this randomized control trial are that a tele-rehabilitation intervention involving video-conferencing with a therapist and use of wearable monitoring devices in the first three months after stroke results in:

* Functional recovery using the LLFDI at 6 months,
* Functional recovery using gait speed, 2-minute walk test and Shah modified Barthel Index at 3 and 6 months,
* Greater contact time with a therapist at 3 \& 6 months,
* Better balance at 3 \& 6 months,
* Better self-report health-related quality of life at 3 \& 6 months,
* Decreased health service utilization at 3 \& 6 months,
* Reduced caregiver burden at three months survivors compared to usual care at 3 \& 6 months.

Conditions

Interventions

OTHER

Tele-rehabilitation

Sponsors & Collaborators

  • Singapore Millennium Foundation

    collaborator UNKNOWN

  • Singapore General Hospital

    collaborator OTHER

  • Ang Mo Kio - Thye Hua Kwan Hospital

    collaborator OTHER

  • National University of Singapore

    lead OTHER

Principal Investigators

  • Shih-Cheng Yes, PhD · National University of Singapore

  • Tay Arthur, PhD · National University of Singapore

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2017-03-31
Completion
2017-09-30

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01905917 on ClinicalTrials.gov